134 related articles for article (PubMed ID: 38348768)
21. PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.
Alessi C; Scapulatempo Neto C; Viana CR; Vazquez VL
Melanoma Res; 2017 Dec; 27(6):565-572. PubMed ID: 28984690
[TBL] [Abstract][Full Text] [Related]
22. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
[TBL] [Abstract][Full Text] [Related]
23. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
24. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
26. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
27. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
[TBL] [Abstract][Full Text] [Related]
28. Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Gallego E; Vicioso L; Alvarez M; Hierro I; Pérez-Villa L; Blanes A; Matilla A
Virchows Arch; 2011 May; 458(5):621-30. PubMed ID: 21279519
[TBL] [Abstract][Full Text] [Related]
29. Indicaxanthin from Opuntia Ficus Indica (L. Mill) impairs melanoma cell proliferation, invasiveness, and tumor progression.
Allegra M; De Cicco P; Ercolano G; Attanzio A; Busà R; Cirino G; Tesoriere L; Livrea MA; Ianaro A
Phytomedicine; 2018 Nov; 50():19-24. PubMed ID: 30466978
[TBL] [Abstract][Full Text] [Related]
30. Targeting drivers of melanoma with synthetic small molecules and phytochemicals.
Strickland LR; Pal HC; Elmets CA; Afaq F
Cancer Lett; 2015 Apr; 359(1):20-35. PubMed ID: 25597784
[TBL] [Abstract][Full Text] [Related]
31. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
32. Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells.
Spender LC; Ferguson GJ; Liu S; Cui C; Girotti MR; Sibbet G; Higgs EB; Shuttleworth MK; Hamilton T; Lorigan P; Weller M; Vincent DF; Sansom OJ; Frame M; Dijke PT; Marais R; Inman GJ
Oncotarget; 2016 Dec; 7(50):81995-82012. PubMed ID: 27835901
[TBL] [Abstract][Full Text] [Related]
33. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
34. Zingerone silences quorum sensing and attenuates virulence of Pseudomonas aeruginosa.
Kumar L; Chhibber S; Kumar R; Kumar M; Harjai K
Fitoterapia; 2015 Apr; 102():84-95. PubMed ID: 25704369
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.
Bracher A; Cardona AS; Tauber S; Fink AM; Steiner A; Pehamberger H; Niederleithner H; Petzelbauer P; Gröger M; Loewe R
J Invest Dermatol; 2013 Jan; 133(1):230-8. PubMed ID: 22951723
[TBL] [Abstract][Full Text] [Related]
36. VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
Pak KH; Park KC; Cheong JH
BMC Cancer; 2019 Aug; 19(1):799. PubMed ID: 31409309
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
39. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
40. Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.
Kinashi H; Ito Y; Sun T; Katsuno T; Takei Y
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
